Respirology

Article	Citations
	150
Reassessing pyrazinamide: Disentangling the myth of dose‐dependent hepatotoxicity and advancing dosing strategies in elderly tuberculosis patients	131
World Lung Day 2025—Healthy Lungs, Healthy Life	108
Effectiveness of Perioperative Radiotherapy With Systemic Therapy on Survival of Squamous Cell Lung Cancer Patients With Pathologic N2	84
Real‐World Evaluation of a Rapid Multiplex PCR Panel in Adults Hospitalized With COPD Exacerbation	66
Response to “Fixed CPAP at 10 cmH2O for OSA: A One‐Size‐Fits‐All Approach?”	63
Trends of global and regional aetiologies, risk factors and mortality of lower respiratory infections from 1990 to 2019: An analysis for the Global Burden of Disease Study 2019	63
Influence of Staphylococcal enterotoxin‐specific IgE sensitization on therapeutic efficacy of omalizumab therapy in severe asthma	58
Issue Information	57
APSR 2024 Abstracts	52
Broadening Our Understanding of Genetic Risk to Interstitial Lung Disease in Understudied Populations	51
Prenatal PM 2 .5 Exposure and Airway Mech	49
The Brompton Breathing Pattern Assessment Tool ( BPAT ): A Journey to Identify the Unknown, a Decade on…	44
Prevention of droplet dispersal with ‘e‐mask’: A new daily use endoscopic mask during bronchoscopy	43
Limitations of Self‐Reported Data in Evaluating COPD Phenotypes and Cardiovascular Risk	42
Language concordance in healthcare: Beyond just talk	41
Omics technologies to study virus infection and chronic lung diseases	40
The Assessment of Subglottic and Cervical Tracheal Stenosis Using a Novel Point‐of‐Care Ultrasound Method: Measurement of Tracheal Radius Curvature	39
Bayesian adaptive clinical trial designs for respiratory medicine	39
Asthma and landscape fire smoke: A Thoracic Society of Australia and New Zealand position statement	38
Effectiveness of Active Video Games as a Training Tool in Patients With Interstitial Lung Disease: A Randomised Controlled Trial	36
	36
Issue Information	36
Predicting Failure: Can Blood Biomarkers Identify Likely Treatment Non‐Responders in IPF?	33
The chicken or the egg: Sleep or physical activity?	31

Enhancing COPD Care for Women: A Predictive Tool for Palliative Needs	31
Antifibrotics and lung transplantation: A Spanish multicentre case‐controlled study	29
Nitrogen dioxide increases the risk of disease progression in idiopathic pulmonary fibrosis	29
Safety and efficacy of bronchial thermoplasty in Australia 5 years post‐procedure	28
Adding some NOVELTY to treatable traits	27
Letter from Canada: Global warming and wildfire smoke pollution emerging as major threats to respiratory health	27
Maximising Participation in the Australian National Lung Cancer Screening Program: A Discrete Choice Experiment of Eligible, High‐Risk Individuals	27
A New Opportunity in Respirology	27
Effects of Air Pollution Exposure and the MUC5B rs35705950 Variant on Interstitial Lung Disease Risk in Patients With Rheumatoid Arthritis	27
From light to sound: Ultrasound outshines Light's criteria for pleural effusions classification	26
Issue Information	26
Letter From The Philippines—Breathing Life Into the Nation: The Philippine College of Chest Physicians and Its Impact on Respiratory Health	26
Allele‐specific micro‐RNA‐mediated regulation of ADAM33 in childhood allergic asthma	25
Effect of antifibrotic agents on postoperative complications after lung transplantation for idiopathic pulmonary fibrosis	25
Predicting Failure at Initiation of High‐Flow Nasal Oxygen in Patients With COVID ‐19: Literature Review, Development and Internal Validation of a Pr	25
Associations of early life and childhood risk factors with obstructive sleep apnoea in middle‐age	25
Smoking, respiratory symptoms, lung function and life expectancy: A longitudinal study of ageing	23
Singing in and out of COVID	23
Obesity is a major contributing cause of breathlessness in the population	23
Proposed quality indicators and recommended standard reporting items in performance of EBUS bronchoscopy: An official World Association for Bronchology and Interventional Pulmonology E	23
Transitional Lung Function Paths in Young Adults: More Opportunities for Prevention?	22
Transplantation of Ex Vivo Amplified Mononuclear Cells From Peripheral Blood Improves Rat Pulmonary Hypertension via CD14 ‐ and <	22
Issue Information	21
Abstract	21
Issue Information	21
	21
My Lungs Have Feelings Too!	20
Pneumothorax in Endobronchial Valve Therapy–Still a Lot to Be Learned	20
Issue Information	19
A Comprehensive Review of Interstitial Lung Abnormalities	19
Correction to “Predictive role of neutrophil‐percentage‐to‐albumin, neutrophil‐to‐lymphocyte and eosinophil‐to‐lymphocyte ratios for mortality in patients with COPD	19
	19
Issue Information	18
An additional mechanism enhancing exercise tolerance in interstitial lung disease with high‐flow nasal cannula	18
Thoracic Society of Australia and New Zealand (TSANZ) Is Abrogating Its Leadership Role in Asia‐Pacific	18
Conspiracy Theories, MDTs and Communication	18
Letter from Australia	17
Promotion of physical activity after hospitalization for COPD exacerbation: Aids and barriers	17
Severe asthma, more than that?	17
Sleep medicine is more than just obstructive sleep apnoea	17
Uncontrolled mild‐to‐moderate asthma may not be mild or moderate, or even asthma: The benefits of early phenotyping	17
A snorkel mask with a 3D‐printed adaptor to HEPA filter was used in a COVID‐19 emergency ward to provide safe respiratory support	17
Chest x‐ray has low sensitivity to detect silicosis in artificial stone benchtop industry workers	16
The 63rd Annual Meeting of the Japanese Respiratory Society	16
The Olympics have arrived: The challenge of exercise‐induced bronchoconstriction in athletes	16
A New Era in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis	16
Erythromycin Shortage in an NTM ‐Endemic Country: Implications for Bronchiectasis Care and Antimicrobial Stewardship	16
Corrigendum	15
Corrigendum	15
Letter from Vietnam	15

Transformative radiology: Chest imaging is being re‐defined	14
Add‐On Dextromethorphan Improves the Effects of Pirfenidone in Bleomycin‐Treated Mice and Patients With Pulmonary Fibrosis	14
Issue Information	14
	14
Letter from the United States: An update on the New York experience with COVID‐19	14
Leading Women in Respiratory Clinical Sciences: Letter From Japan	14
Author Index	14
	14
	13
Hansen's disease and the first patient disease Registry	13
Presence of anti‐modified protein antibodies in idiopathic pulmonary fibrosis	13
High Flow Nasal Oxygen and Low Flow Oxygen Are Equally Effective in Providing Oxygenation During Bronchoscopy Under Conscious Sedation: A Randomised Controlled Trial	13
Letter from Korea	13
Correction to APSR Annual Conference ‐ 28th Congress of the Asian Pacific Society of Respirology, 7–10 November 2024, Hong Kong.	13
Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study	13
Validation of the clinical utility of sGaw as a response variable in methacholine challenge testing	13
Innovations in thoracic imaging: CT, radiomics, AI and x‐ray velocimetry	12
The United Nations Framework Convention on Climate Change (UNFCCC) 28th Conference of the Parties, Dubai (COP28): Implications for lung disease	12
Feasibility of a Modified Bronchoscopic Transparenchymal Nodule Access Technique (‘Essen Tunnel’) for Improving the Diagnosis of Intraparenchymal Pulmonary Lesions	12
Determinants of radiation exposure during mobile cone‐beam CT‐guided robotic‐assisted bronchoscopy	12
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe	12
	12
Issue Information	11
Global, regional and national burden of chronic obstructive pulmonary disease over a 30‐year period: Estimates from the 1990 to 2019 Global Burden of Disease Study	11
A visit to the gallery	11
Prognostic Value of a Cardiopulmonary Exercise Testing‐Derived Summed Score in Idiopathic Pulmonary Fibrosis and Connective Tissue Disease‐Associated Interstitial Lung Disease: A Prospective Cohort St	11
Association of short‐term exposure to PM1 with hospital admission from total and cause‐specific respiratory diseases	11
Development and Validation of a Clinical Scoring System Predicting 30‐Day Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis	11
Correction to “ APSR Annual Conference ‐ 28th Congress of the Asian Pacific Society of Respirology, 7–10 November 2024, Hong Kong.	11
Issue Information	11
	11
Safety and efficacy of a novel transbronchial radiofrequency ablation system for lung tumours: One year follow‐up from the first multi‐centre large‐scale clinical trial ( BRON	11
	11
A comprehensible machine learning tool to differentially diagnose idiopathic pulmonary fibrosis from other chronic interstitial lung diseases	10
Illness, chocolate and Harry Potter	10
Patients' and Health Professionals' Views on Using Oral Corticosteroids for Asthma: Priorities, Trade‐Offs and Shared Decision‐Making	10
Pathways linked to unresolved inflammation and airway remodelling characterize the transcriptome in two independent severe asthma cohorts	10
Adaptation in real time: Wildfire smoke exposure and respiratory health	10
Letter from Iceland	10
Ηeparan sulphate in infectious and non‐infectious exacerbations of COPD	10
Current evidence on supranormal lung function: A call for longitudinal research to optimize lung health	10
Breath‐holding physiology, radiological severity and adverse outcomes in COVID‐19 patients: A prospective validation study	10
Robotic One Anaesthetic Marking And Resection ( ROMAR ): A Novel Approach for Thoracoscopic Sublobar Resection of Peripheral Pulmonary Lesions	10
Issue Information	9
A Mechanistic and Morphologic Approach to Managing Benign Central Airway Obstruction	9
Letter From the Sri Lanka College of Pulmonologists	9
Elevated blood lactate in COPD exacerbations associates with adverse clinical outcomes and signals excessive treatment with β2‐agonists	9
Small Airways and Pulmonary Diffusing Capacity Decline in an 8‐Year Longitudinal Population Study	9
A Novel Method Using Dual‐Energy Computed Tomography for Detecting Amiodarone‐Induced Lung Injury: A Cohort Pilot Study	9
Tackling a Lifetime of Risk for OSA	9
Contemporary Concise Review 2023: Interstitial lung disease	9
NT ‐ proBNP and BNP Testing in Pulmonary Arterial Hypertension: Poi	9
Breathlessness: Remembering the worst of it	8
The Association Between Use of Inhaled Corticosteroids and Long‐Acting Beta2‐Agonists During Pregnancy and Adverse Fetal Outcomes	8
Beyond Single Cytokines: Targeting Co‐Receptor CD131 in Asthma‐COPD Overlap	8
Siloed thinking is limiting health care delivery	8
Urban living	8
Recommendations from the Medical Education Editor	8
The hidden costs of living with systemic sclerosis‐associated interstitial lung disease	8
Thoracic Society of Australia and New Zealand position statement: The safe clinical use of sputum induction for bio‐sampling of the lower airways in children and adults	8
Reply to: ‘Is continuous positive airway pressure truly superior to high‐flow nasal cannula in managing acute hypoxemic respiratory failure?’	8
Letter from the Czech Republic	8
Cough suppression as a radical but effective therapeutic strategy	8
Smoking: Quit to win	8
Consumer engagement—Beyond the usual approaches	8
Looking Towards More Comprehensive Management of Interstitial Lung Disease	8
Understanding Nontuberculous Mycobacterial Pulmonary Disease as a Chronic Lung Disease	7
Leading women in respiratory clinical sciences: Letter from Australia	7
Effect of an artificial intelligence tool on management decisions for indeterminate pulmonary nodules	7
COPD‐related incidence, mortality, and disability: An illustrative summary of the GBD study (1990–2019)	7
Plastics in Every Breath: The Silent Respiratory Health Threat We Cannot Avoid	7
The treatable traits approach to adults with obstructive airways disease in primary and secondary care	7
Right Atrial Pressure/Pulmonary Artery Wedge Pressure Ratio Correlates With Early Outcomes After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension	7
Letter from Thailand	7
Home sweet home… or is it?	7
The Oxygenation Benefits Provided by High‐Flow Nasal Oxygen in Bronchoscopy May Be Underestimated	7
Recommendations from The Medical Education Editor	7
Extracellular traps are evident in Romanowsky‐stained smears of bronchoalveolar lavage from children with non‐cystic fibrosis bronchiectasis	7
World Lung Day 2023—Access to prevention and treatment for all, leave no one behind	7
	7

Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial	7
World Association for Bronchology and Interventional Pulmonology (WABIP) guidelines on airway stenting for malignant central airway obstruction	7
Inflammation‐induced loss of CFTR ‐expressing airway ionocytes in non‐eosinophilic asthma	7
The Western Australian Mesothelioma Registry: Analysis of 60 years of cases	7
Contemporary Concise Review 2023: Environmental and occupational lung diseases	7
Increased exacerbations of bronchiectasis following recovery from mild COVID‐19 in patients with non‐cystic fibrosis bronchiectasis	7
Addressing the Global Challenges of COPD and Asthma: A Shared Vision From the Global Initiative for Chronic Obstructive Pulmonary Disease (	7
Ipsilateral and contralateral hemidiaphragm dynamics in symptomatic pleural effusion: The 2nd PLeural Effusion And Symptom Evaluation (PLEASE‐2) Study	6
Nintedanib in Asian patients with progressive fibrosing interstitial lung diseases: Results from the INBUILD trial	6
Atomoxetine and fesoterodine combination improves obstructive sleep apnoea severity in patients with milder upper airway collapsibility	6
Small babies at birth, small lungs for life?	6
Issue Information	6
Letter from the UK: Reflections on a turbulent 5 years	6
Cardiovascular Effect of Snoring in Asians: What Do Biobank and Genomic Studies Say?	6
Issue Information	6
Racial and ethnic disparities in antifibrotic therapy in idiopathic pulmonary fibrosis	6
Stirring the publishing pot by ending accept/reject decisions	6
Long‐term trends of COPD mortality: Gaps and opportunities	6
The Case for Case Finding Is Getting Stronger	6
Breaking the spiral: How negative mood can fuel exertional breathlessness in people with chronic obstructive pulmonary disease	6
Pre‐transplant anti‐fibrotics for idiopathic pulmonary fibrosis: Are we seeing a new role for the anti‐fibrotics?	6
Vaccination in patients with COPD: COVID has raised the bar	6
Letter from South Africa	6
Into the meaning of Respirology, Pulmonology and Pneumology	6
Quantitative computed tomography of the chest for fibrotic lung diseases: Prime time for its use in routine clinical practice?	6
Comparing recalled versus experienced symptoms of breathlessness ratings: An ecological assessment study using mobile phone technology	6
Issue Information	6
Reliability of Rapid On‐Site Evaluation Achieved by Remote Sharing Systems (E‐ ROSE ) and AI Algor	6
Clinical trials and clinical trials networks	6
Letter from Belgium	6
Contemporary Concise Review 2024: Respiratory Infections	6
Overexpression of SMAD7 improves the function of EGFR‐targeted human CAR‐T cells against non‐small‐cell lung cancer	5
Letter From the Vietnam Respiratory Society—Vietnam's Respiratory Medicine in Transition: From Clinical Advances to National Healthcare Policy	5
Pathological Examination and Genetic Mutation Testing: Bridging Their Best Practices Using MINtS	5
Objective Effects and Patient Preferences for Ambulatory Oxygen in Fibrotic Interstitial Lung Disease With Isolated Exertional Hypoxaemia: A Placebo‐Controlled 6‐Minute Walk Test Study	5
Molecular Investigation in Early‐Onset Interstitial Lung Disease: Results From 699 Unrelated Patients	5
Benefits of chest wall mobilization on respiratory efficiency and functional exercise capacity in people with severe chronic obstructive pulmonary disease (COPD): A randomized controlled tr	5
Upadacitinib Versus Tofacitinib in Anti‐ MDA5 ‐Positive Dermatomyositis With Interstitial Lung Disease: A Multi‐Centre Cohort Study Emulating a Targe	5
Author Index	5
Targeting the human βc receptor inhibits inflammatory myeloid cells and lung injury caused by acute cigarette smoke exposure	5
Correction to “Feasibility of a Modified Bronchoscopic Transparenchymal Nodule Access Technique (‘Essen Tunnel’) for Improving the Diagnosis of Intraparenchymal Pulmonary Lesions”	5
A snapshot of SABA co‐prescribing with ICS‐formoterol maintenance and reliever therapy	5
	5
Safety of pyrazinamide in elderly patients with tuberculosis in Japan: A nationwide cohort study	5
	5
Covid‐19 pandemic and asthma: What did we learn?	5
Contemporary Concise Review 2021: Interstitial lung disease	5
Quantum Respiratory Science	5
What Matters for Prediction? Leukocyte Count and Risk Stratification in Pulmonary Embolism	5
Issue Information	5
	5
Checkpoint inhibitors are a basic science‐based, transformative new treatment for lung cancer	5
Effect of pulmonary rehabilitation duration on exercise capacity and health‐related quality of life in people with chronic obstructive pulmonary disease	5
Environmental impact of inhaled medicines: A Thoracic Society of Australia and New Zealand position statement	5
	5
Risk of childhood asthma in those born small	5
Small for gestational age is associated with reduced lung function in middle age: A prospective study from first to fifth decade of life	4
Issue Information	4
Clinical Presentation and Diagnostic Evaluation of Vaping Related Lung Injury in Youth	4
PMN‐MDSCs Orchestrate the Immunosuppressive Microenvironment in the Lung and Are Associated With Clinical Outcome in Bronchiectasis	4
How does one get around many of the confounding factors influencing the response to methacholine?	4
Non‐Intubated VATS for Interstitial Lung Disease Diagnosis: A Safer Technique or Too Soon to Tell?	4
Effects of early mobilization on patients with COVID‐19 with respiratory failure	4
Evaluating artificial intelligence responses to respiratory medicine questions	4
Obstructive Sleep Apnoea Treatments—Where Are We Now?	4
Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics	4
Aetiology of Adult Community‐Acquired Lung Abscess in Hong Kong	4
Benralizumab and mepolizumab treatment outcomes in two severe asthma clinics	4
Reply to “Familial Segregation Highlights Challenges in Rare SFTPA2 Variant Classification”	4
Rheumatoid factor and anti‐citrullinated antibodies in non‐connective tissue interstitial lung disease: The chicken or the egg?	4
Sputum Metagenomics Reveals Multidrug‐Resistant Pseudomonas‐Dominant Communities in Severe Asthma	4
Recommendations From the Medical Education Editor	4
TSANZ Abstracts	4
Optimal clinical practice in IPF and PPF: Integrating the scientific ethos and clinical reasoning	4
Lifetime Body Mass Index Trajectories and Contrasting Lung Function Abnormalities in Mid‐Adulthood: Data From the Tasmanian Longitudinal Health Study	4
A paediatric bronchoscopist's ‘Field of Dreams’: Will the flexible cryoprobe hit a home run?	4
CD131 antagonism blocks inflammation, emphysema and fibrosis in an asthma‐COPD overlap mouse model originating in early life	4
Issue Information	4
Heated Tobacco Product Use and Lower Physical Activity Among Japanese Adults With and Without Respiratory Diseases: Findings From the JACSIS Study	4
Food for the Lungs: The Mediterranean Diet and Adult‐Onset Asthma	4
Endotyping in sleep surgery: Not ready for primetime	4
Familial Segregation Highlights Challenges in Rare SFTPA2 Variant Classification	4
PDE5 to keep them alive: The use of phosphodiesterase type‐5 inhibitors in severe pulmonary hypertension associated with interstitial lung disease	4
Which biologic? New findings from a real‐world study	4
Diffusion capacity and static hyperinflation as markers of disease progression predict 3‐year mortality in COPD: Results from COSYCONET	4
Auto‐adjusted versus fixed positive airway pressure in patients with severe OSA: A large randomized controlled trial	4
Inter‐Night Variability of Nocturnal Pulse Oximetry in People Living With Motor Neuron Disease: A Retrospective Observational Study	4
Bronchiectasis: A pulmonary disease with systemic consequences	4
The role of obstructive sleep apnoea in cognitive dysfunction of the elderly: A therapeutic target or Pandora's box?	4
Leading women in Respiratory Medicine: Letter from the ERS	4
From Residency to Tissue Inflammatory Memory: HLF as a Transcriptional Gatekeeper of CD4 +	4
Issue Information	4
Pre‐Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients	4
Virtual bronchoscopic navigation and endobronchial ultrasound with a guide sheath without fluoroscopy for diagnosing peripheral pulmonary lesions with a bronchus leading to or adjacent to the lesion:	4
Hypoxic indices for obstructive sleep apnoea severity and cardiovascular disease risk prediction: A comparison and application in a community population	4